IFN-Α

DRUG2 trials

Sponsors

Peking University People's Hospital

Conditions

Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloid Leukemia

Phase 2

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

RecruitingNCT06130579

Peking University People's HospitalMyelodysplastic Syndromes, Myeloid Leukemia

Start: 2024-01-01End: 2026-06-30Target: 35Updated: 2025-06-03

IFN-α in Relapse Prevention.

Not yet recruitingNCT07449286

Peking University People's HospitalAcute Myeloid Leukemia, Myelodysplastic Syndromes

Start: 2026-03-01End: 2027-06-30Target: 100Updated: 2026-03-04